Werewolf Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update May 12, 2023
Werewolf Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update May 11, 2023
Longwood Healthcare Leaders to Convene Top Biotech and Pharmaceutical Leaders at MIT Koch Institute May 11, 2023
TScan Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update May 10, 2023
Lassen Therapeutics Announces Oral Presentation of Phase I Data of LASN01, an IL-11 Receptor-Blocking Antibody for Treatment of Pulmonary Fibrosis May 10, 2023
Interius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced Therapies May 9, 2023
